— Know what they know.
Not Investment Advice

ASRT NASDAQ

Assertio Holdings, Inc.
1W: +0.3% 1M: +0.8% 3M: +99.7% YTD: +157.1% 1Y: +3709.4% 3Y: +290.4% 5Y: +1163.4%
$23.50
Last traded 2026-06-15 — delisted
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · $151.9M mcap · 6M float · 5.23% daily turnover · Short 57% of daily vol

Revenue Segmentation

By Product / Service

By Geography

Revenue by Segment (5-Year Trend)

Income Trends

Revenue
$119M -5.0% ▼
5Y CAGR: +1.9%
Gross Profit
$83M -2.8% ▼
5Y CAGR: -2.0%
Operating Income
-$22M +12.0% ▲
Net Income
-$30M -36.7% ▼
EPS (Diluted)
$-4.74 -37.4% ▼
EBITDA
$13M +148.4% ▲

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
Revenue$111M$156M$152M$125M$119M
YoY Growth+4.5%+40.7%-2.7%-17.8%-5.0%
Cost of Revenue$16M$19M$27M$39M$35M
Gross Profit$95M$137M$125M$86M$83M
Gross Margin85.7%88.0%82.2%68.6%70.2%
R&D Expenses$0$0$3M$4M$2M
SG&A Expenses$57M$48M$70M$77M$69M
Operating Expenses$86M$98M$369M$110M$105M
Operating Income$9M$39M-$244M-$24M-$22M
Operating Margin8.5%25.2%-160.1%-19.6%-18.1%
Interest Expense$10M$8M$3M$3M$3M
Income Before Tax-$553K$31M-$254M-$22M-$30M
Tax Expense$728K-$78M$78M$52K-$435K
Net Income-$1M$110M-$332M-$22M-$30M
Net Margin-1.2%70.2%-218.3%-17.3%-24.9%
EPS (Diluted)$-0.03$2.03$-4.67$-0.23$-4.74
EBITDA$39M$90M$53M$5M$13M
Shares Outstanding43M55M71M95M6M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms